Highly Axial Magnetic Anisotropy in a N3O5 Dysprosium(III) Coordination Environment Generated by a Merocyanine Ligand

A spiropyran‐based switchable ligand isomerizes upon reaction with lanthanide(III) precursors to generate complexes with an unusual N₃O₅ coordination sphere. The air‐stable dysprosium(III) complex shows a hysteresis loop at 2 K and a very strong axial magnetic anisotropy generated by the merocyanine phenolate donor.     

Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation

Matching of symmetry at interfaces is a fundamental obstacle in molecular assembly. Virus‐like particles (VLPs) are important vaccine platforms against pathogenic threats, including Covid‐19. However, symmetry mismatch can prohibit vaccine nanoassembly. We established an approach for coupling VLPs to diverse antigen symmetries. SpyCatcher003 enabled efficient VLP conjugation and extreme thermal resilience. Many people had pre‐existing antibodies to SpyTag:SpyCatcher but less to the 003 variants. We coupled the computer‐designed VLP not only to monomers (SARS‐CoV‐2) but also to cyclic dimers (Newcastle disease, Lyme disease), trimers (influenza hemagglutinins), and tetramers (influenza neuraminidases). Even an antigen with dihedral symmetry could be displayed. For the global challenge of influenza, SpyTag‐mediated display of trimer and tetramer antigens strongly induced neutralizing antibodies. SpyCatcher003 conjugation enables nanodisplay of diverse symmetries towards generation of potent vaccines.     

A new benchmark for transient analysis of laminated plate elements

Conclusions In this paper, a new benchmark was presented to verify the finite element method programs for analysis of composite element impact problems. The benchmark presented possesses a double contact between the impactor and the laminated plate. The results of the analytical solution were presented, and compared with the results obtained by a commercially available FEM-program. This work was an example of a numerical solution method verification, and the test was found suitable as a benchmark due to its simplicity in modeling and its versatility in assessing programs.Published in Mekhanika Kompozitnykh Materialov, Vol. 31, No. 2, pp. 209–215, March–April, 1995.Presented at the Ninth International Conference on the Mechanics of Composite Materials (Riga, October, 1995).     

Structure of antitumor agents 2-acetylpyridinethiosemicarbazone hemihydrate and 2-acetylpyridinethiosemicarbazone hydrochloride

The structures of two antitumor agents, 2-acetylpyridinethiosemicarbazone hemihydrate (1), C₁₈H₁₁N₄O_0.5S, colorless,M _r 203.3, monoclinic,P2₁ lc,a=16.713(3),b=9.460(2),c=12.642(2) ?, β=97.60(1)°,V=1981.2(6) ?³,Z=8,R=0.054,R _w =0.085 and 2-acetylpyridinethiosemicarbazone hydrochloride (2), C₁₈H₁₂N₄SCl, yellow,M _r =230.7, monoclinic,P2₁ ln,a=7.676(2),b=7.889(1),c=17.452(4), ?, β=100.96(2)°,V=1037.5(4) ?³ Z=4,R=0.041,R _w =0.076, have been determined. Both compounds exhibit an E configuration(S atomtrans to the N atom of the hydrazine group). Three hydrogen bonds link the two crystallographically independent molecules in a pairwise fashion in the hemihydrate. An intramolecular N−H...Cl bond lends extra conformational stability to the hydrochloride salt.     

Generic fast gradient liquid chromatography/tandem mass spectrometry techniques for the assessment of the in vitro permeability across the blood-brain barrier in drug discovery

Rapid, generic gradient liquid chromatography/tandem mass spectrometry (LC/MS/MS) assays, designed to accelerate sample analyses, have been developed to keep pace with the productivity of advanced synthetic procedures. In this study, LC/MS/MS was combined with an in vitro, cell-based, blood-brain barrier (BBB) model to evaluate the potential of new chemical entities (NCEs) to cross the BBB. This in vitro assay provides the permeability of discovery compounds across a monolayer of a primary culture of bovine brain microvessel endothelial cells in a fraction of the time that is required for in vivo studies (brain/plasma concentrations), using only 2 mg of the compound. The results are consistent with in vivo brain/plasma concentration ratio data.     

Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048)

Posaconazole (SCH 56592) is a novel triazole antifungal drug that is marketed in Europe and the United States under the trade name 'Noxafil' for prophylaxis against invasive fungal infections. SCH 56592 was discovered as a possible active metabolite of SCH 51048, an earlier lead. Initial studies have shown that serum concentrations determined by a microbiological assay were higher than those determined by HPLC from animals dosed with SCH 51048. Subsequently, several animals species were dosed with (3)H-SCH 51048 and the serum was analyzed for total radioactivity, SCH 51048 concentration and antifungal activity. The antifungal activity was higher than that expected based on SCH 51048 serum concentrations, confirming the presence of active metabolite(s). Metabolite profiling of serum samples at selected time intervals pinpointed the peak that was suspected to be the active metabolite. Consequently, (3)H-SCH 51048 was administered to a large group of mice, the serum was harvested and the metabolite was isolated by extraction and semipreparative HPLC. LC-MS/MS analysis suggested that the active metabolite is a secondary alcohol with the hydroxyl group in the aliphatic side chain of SCH 51048. All corresponding monohydroxylated diastereomeric mixtures were synthesized and characterized. The HPLC retention time and LC-MS/MS spectra of the diastereomeric secondary alcohols of SCH 51048 were similar to those of the isolated active metabolite. Finally, all corresponding individual monohydroxylated diasteriomers were synthesized and evaluated for in vitro and in vivo antifungal potencies, as well as pharmacokinetics. SCH 56592 emerged as the candidate with the best overall profile.     

Synthesis,spectroscopic and structural characterization of the mer isomer of ammonium bis(phenylpyruvic acid thiosemicarbazone)-cobalt(III) hemihydrate

Summary Phenyl pyruvate thiosemicarbazone (H₂PPVATSC) coordinates in its binegative thiolate form to cobalt(III) in the complex isolated from basic medium. An X-ray structure determination of the resulting meridional isomer was found to contain mutually cis sulphur, trans nitrogen, and trans oxygen donor atoms, respectively. The two five-membered rings formed by each ligand are puckered towards each other, resulting in a distortion from regular octahedral geometry about the cobalt atom. The complex was found to exhibit only a metal-based one electron reversible reduction at -0.97 V, while the parent ligand yields a c.v. profile consisting of two irreversible reduction peaks at -0.75 and -1.05V respectively, the latter corresponding to the reduction of the azomethine group.